Page last updated: 2024-08-23

alkenes and Carcinoma, Oat Cell

alkenes has been researched along with Carcinoma, Oat Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Jong, RS; de Vries, EG; Groen, HJ; Höppener, FJ; Mulder, NH; Sleijfer, DT; Uges, DR; van der Graaf, WT; Willemse, PH1
de Jong, S; de Vries, EG; Mulder, NH; Zijlstra, JG1

Trials

1 trial(s) available for alkenes and Carcinoma, Oat Cell

ArticleYear
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.
    British journal of cancer, 1999, Volume: 79, Issue:5-6

    Topics: Adult; Aged; Alanine Transaminase; Alkenes; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Half-Life; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Polyenes; Pyrones; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1999

Other Studies

1 other study(ies) available for alkenes and Carcinoma, Oat Cell

ArticleYear
Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:6

    Topics: Alkenes; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Cell Line; Cell Nucleus; DNA Topoisomerases, Type II; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Methotrexate; Polyenes; Pyrones; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1991